Author:
Jachimczak Piotr,Bogdahn Ulrich,Hau Peter
Publisher
Springer Berlin Heidelberg
Reference96 articles.
1. Agrawal, S., Kandimalla, E.R. (2001). Antisense and/or Immunostimulatory Oligonucleotide Therapeutics. Curr Cancer Drug Targets, 1:197–209.
2. Akhurst, R.J. (2006). Large- and small-molecule inhibitors of transforming growth factor-ß signaling. Curr Opin Investig Drugs, 7:513–521.
3. Akhurst, R.J., Derynck, R. (2001). TGF-beta signaling in cancer – a double-edged sword. Trends Cell Biol, 11:44–51.
4. Andrews, D.W., Resnicoff, M., Flanders, A.E et al (2001). Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas. J Clin Oncol, 19(8):2189–2200.
5. Arslan, F., Bosserhoff, A.K., Nickl-Jockschat, T et al (2007). The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-beta2. Br J Cancer, 96(10):1560–1568.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献